Return to search

DRUG DELIVERY SOLUTIONS FOR THE POTENTIAL TREATMENT OF CHILDHOOD OCULAR CONDITIONS

Ocular drug delivery remains a challenge due to the anatomical and physiological barriers of the eye. Topical drops have poor penetration and side effects, and injections are highly invasive; an alternative approach is transscleral delivery. Sustained drug release systems utilizing this delivery pathway are non-invasive yet provide extended treatment periods with single doses. Specifically, such systems would be beneficial for treating pediatric populations for diseases such as retinoblastoma and myopia. A chemo-preventative treatment for retinoblastoma, a childhood ocular cancer, has been proposed utilizing CdK inhibitors such as roscovitine and R547. Myopia, a more common, chronic condition in children, can be treated with atropine, though the dosing must be tightly controlled. Three novel delivery systems have been developed in this work to deliver these drugs, generating potential treatment platforms for these conditions.
Contact lenses have been investigated previously to deliver various therapeutics, as they act as a slow, equilibrating reservoir, and the prolonged corneal residence time improves bioavailability. Silicone lenses, with their ability for continuous wear, have been explored looking at various material compositions and drug loading levels and techniques to confirm the feasibility of this system for these conditions (Chapter 2). This work has been extended to include covalent tethers for roscovitine, ensuring that it is able to survive a more commercially-relevant synthesis and providing additional ways to tailor the drug release profiles (Chapter 3).
Alternatively, amphiphiles, which can self-assemble in the presence of excess water, have been explored for their drug delivery potential. Novel materials consisting of oleoylethanolamide and linoleoylethanolamide were developed to exhibit cubic phase transitions at physiologically relevant conditions, and their subsequent drug release characteristics were explored (Chapter 4). Silicone-based materials have broad usages as biomaterials, and a novel approach of incorporating PEG into the material without the use of metal catalysts were explored (Chapter 5). These exhibited a significant reduction in protein fouling, and material compositions were further iterated on, and their subsequent drug delivery capabilities were examined (Chapter 6). Overall, these three approaches have been able to successfully delivery roscovitine, R547 and atropine in non-invasive manners that have the potential to be an appropriate treatment for the childhood conditions they are intended to treat. / Dissertation / Doctor of Philosophy (PhD) / Sustained ocular drug delivery is critical to minimize side effects, maximize compliance and improve the clinical outcomes experienced by the patient. This is particularly true in pediatric applications, such as retinoblastoma and myopia. The objective of this thesis is to create drug delivery systems that could be used to treat these childhood conditions, with a focus on non-invasive delivery technologies.
In this project, contact lenses are explored as drug delivery vehicles for two drugs which can be used to treat retinoblastoma and myopia. Multiple materials and drug loading are explored to create a sustained drug delivery system that meets the needs of these conditions. This is then expanded into examining systems that fit within current commercial manufacturing practices, creating a delivery system that meets the demands of the disease and industry.
Alternative delivery systems that could be utilized as inserts are also explored. A lipid based system, whose materials are native to the body, are explored as a unique system capable of delivering drugs in a controlled fashion under specific hydration and temperature conditions. Alternatively, a silicone-based system is explored, whose unique chemistry eliminates many of the prohibitive biological side effects seen with these materials, allowing for a sustained drug delivery system for these ocular conditions.

Identiferoai:union.ndltd.org:mcmaster.ca/oai:macsphere.mcmaster.ca:11375/24393
Date January 2019
CreatorsLasowski, Frances
ContributorsSheardown, Heather, Chemical Engineering
Source SetsMcMaster University
LanguageEnglish
Detected LanguageEnglish
TypeThesis

Page generated in 0.0024 seconds